DRS — Leonardo DRS, Inc.

Summary of DRS Q3 2025 Earnings Call

1. Key Financial Results and Metrics

• Revenue: Q3 revenue increased by 18% year-over-year to $960 million.
• Bookings: Strong bookings of $1.3 billion resulted in a book-to-bill ratio of 1.4x for the quarter and 1.2x year-to-date.
• Backlog: Total backlog reached a record $8.9 billion, up 8% year-over-year, with a funded backlog growth of 20%.
• Adjusted EBITDA: Increased by 17% to $117 million, with a margin of 12.2%, slightly down from the previous year.
• Net Earnings: Q3 net earnings were $72 million, with diluted EPS of $0.26, reflecting a 26% increase.
• Free Cash Flow: Rose significantly to $77 million, driven by improved working capital efficiency.

2. Strategic Updates and Business Highlights

• Market Demand: Continued strong demand for counter UAS, advanced infrared sensing, naval network computing, and electric power and propulsion technologies.
• Product Innovations: Introduction of SAGEcore, an AI-integrated operating system for tactical platforms, and THOR, a multifunction network computing product.
• Operational Success: DRS secured over $250 million in contracts for counter UAS and short-range air defense programs.
• Supply Chain Initiatives: Progress in strengthening the germanium supply chain through recycling and strategic partnerships to ensure supply for 2026.

3. Forward Guidance and Outlook

• Revenue Growth: Full-year revenue growth expectations revised to 10% to 11%, with guidance for total revenue in the range of $3.55 billion to $3.6 billion.
• Adjusted EBITDA: Guidance maintained between $437 million and $453 million.
• Adjusted EPS: Expected to be between $1.07 and $1.12 per share, with an effective tax rate of 18%.
• 2026 Outlook: Early budgeting process underway, with a focus on organic growth and expanding adjusted EBITDA margins.

4. Bad News, Challenges, or Points of Concern

• Government Shutdown: The ongoing U.S. government shutdown poses potential risks for delays in awards and payments, although no significant impacts have been felt yet.
• R&D Investment Impact: Increased investment in internal research and development is constraining margins, particularly in the ASC segment.
• Germanium Supply Issues: While progress is being made, reliance on germanium remains a concern, with potential impacts on profitability due to higher alternative supply costs.

5. Notable Q&A Insights

• IRAD Spending: Management expects internal research and development investment to remain steady, reflecting the need for agility in a dynamic market.
• Foreign Military Sales: Anticipated ramp-up in foreign military sales, particularly in counter UAS and sensor technologies.
• Counter UAS Market: DRS holds a strong position in the counter UAS market, with approximately 20% of revenues tied to these efforts.
• M&A Strategy: Hoverfly investment aligns with DRS's strategy to enhance unmanned capabilities and is seen as a potential growth driver.
• Columbia Class Program: Revenue from the Columbia Class program is stable, with expectations for improved margins starting in 2026.

Overall, DRS reported strong financial performance in Q3 2025, driven by robust demand in key areas, while navigating challenges such as the government shutdown and supply chain constraints. The leadership transition and strategic initiatives position the company for continued growth.